Bivalirudin Anticoagulant Therapy With or Without Platelet Glycoprotein IIb/IIIa Inhibitors During Transcatheter Coronary Interventional Procedures: A Meta-Analysis

The safety and effectiveness of using the direct thrombin inhibitor bivalirudin during transcatheter coronary interventional procedures remains uncertain. This study aimed to systematically assess anticoagulation with bivalirudin alone or bivalirudin plus glycoprotein (GP) IIb/IIIa inhibitors (bival...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jiabei, Yu, Shiyong, Qian, Dehui, He, Yun, Jin, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
3400
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616679/
https://www.ncbi.nlm.nih.gov/pubmed/26266343
http://dx.doi.org/10.1097/MD.0000000000001067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616679/
https://www.ncbi.nlm.nih.gov/pubmed/26266343
http://dx.doi.org/10.1097/MD.0000000000001067

Ejemplares similares